In sum, these data suggest that, in individuals with obesity and insulin resistance, GLP-1, GIP and glucagon are likely to increase AT’s metabolic efficiency despite this effect being attained via different mechanisms and potentially acting in synergy. This evidence concerns the gene GIP and Obesity.